Moreover, the 36-month beta value for ANNX is 1.14. Analysts have varying opinions on the stock, with 5 analysts rating it as a “buy,” 3 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ANNX is 92.63M and currently, short sellers hold a 10.90% of that float. On February 28, 2025, ANNX’s average trading volume was 1.35M shares.
ANNX) stock’s latest price update
The stock of Annexon Inc (NASDAQ: ANNX) has decreased by -3.85 when compared to last closing price of 2.60. Despite this, the company has experienced a -11.66% fall in its stock price over the last five trading sessions. globenewswire.com reported 2025-02-26 that BRISBANE, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today announced that Douglas Love, president and chief executive officer, will present at the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4, 2025 at 11:50 a.m. EST.
ANNX’s Market Performance
Annexon Inc (ANNX) has experienced a -11.66% fall in stock performance for the past week, with a -39.02% drop in the past month, and a -51.36% drop in the past quarter. The volatility ratio for the week is 6.37%, and the volatility levels for the past 30 days are at 7.20% for ANNX. The simple moving average for the last 20 days is -20.52% for ANNX stock, with a simple moving average of -54.15% for the last 200 days.
Analysts’ Opinion of ANNX
Many brokerage firms have already submitted their reports for ANNX stocks, with JP Morgan repeating the rating for ANNX by listing it as a “Overweight.” The predicted price for ANNX in the upcoming period, according to JP Morgan is $11 based on the research report published on March 01, 2024 of the previous year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see ANNX reach a price target of $6, previously predicting the price at $4. The rating they have provided for ANNX stocks is “Buy” according to the report published on December 21st, 2023.
Wells Fargo gave a rating of “Overweight” to ANNX, setting the target price at $11 in the report published on October 30th of the previous year.
ANNX Trading at -39.14% from the 50-Day Moving Average
After a stumble in the market that brought ANNX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -70.24% of loss for the given period.
Volatility was left at 7.20%, however, over the last 30 days, the volatility rate increased by 6.37%, as shares sank -39.32% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -44.57% lower at present.
During the last 5 trading sessions, ANNX fell by -11.66%, which changed the moving average for the period of 200-days by -50.98% in comparison to the 20-day moving average, which settled at $3.15. In addition, Annexon Inc saw -51.27% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ANNX starting from Dananberg Jamie, who sale 5,521 shares at the price of $2.96 back on Feb 18 ’25. After this action, Dananberg Jamie now owns 33,479 shares of Annexon Inc, valued at $16,342 using the latest closing price.
ARTIS DEAN RICHARD, the EVP & CHIEF SCIENTIFIC OFFICER of Annexon Inc, sale 5,515 shares at $2.97 during a trade that took place back on Feb 18 ’25, which means that ARTIS DEAN RICHARD is holding 83,814 shares at $16,380 based on the most recent closing price.
Stock Fundamentals for ANNX
Current profitability levels for the company are sitting at:
- -27.05 for the present operating margin
- 0.48 for the gross margin
The net margin for Annexon Inc stands at -24.15. The total capital return value is set at -0.37. Equity return is now at value -48.12, with -40.34 for asset returns.
Based on Annexon Inc (ANNX), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at -3.56. The debt to equity ratio resting at 0.09. The interest coverage ratio of the stock is -42.43.
Currently, EBITDA for the company is -141.57 million with net debt to EBITDA at 0.39. When we switch over and look at the enterprise to sales, we see a ratio of 44.5. The liquidity ratio also appears to be rather interesting for investors as it stands at 17.18.
Conclusion
To wrap up, the performance of Annexon Inc (ANNX) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
